Article info

Download PDFPDF
Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

Authors

  1. Correspondence to Dr Oday Elmanaseer; elmanao{at}amc.edu
View Full Text

Citation

Elmanaseer O, Avelino ARM, Azem A, et al
Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

Publication history

  • Accepted November 25, 2021
  • First published December 22, 2021.
Online issue publication 
December 22, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.